PharmaCielo (TSXV:PCLO) Change In Payables And Accrued Expense : C$2.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Change In Payables And Accrued Expense?

PharmaCielo's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2023 was C$0.75 Mil. It means PharmaCielo's Accounts Payable & Accrued Expense increased by C$0.75 Mil from Jun. 2023 to Sep. 2023 .

PharmaCielo's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was C$-0.35 Mil. It means PharmaCielo's Accounts Payable & Accrued Expense declined by C$0.35 Mil from Dec. 2021 to Dec. 2022 .

PharmaCielo Change In Payables And Accrued Expense Historical Data

The historical data trend for PharmaCielo's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Change In Payables And Accrued Expense Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.01

-0.45

9.78

-4.47

-0.35

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.43	0.75	0.38	0.13	0.75

PharmaCielo Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.00 Mil.

PharmaCielo Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo (TSXV:PCLO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan

Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines